ITP
BHVN icon

Iron Triangle Partners’s Biohaven BHVN Stock Holding History

Iron Triangle Partners’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$10.8M Buy
+958,336
New +$11.9M 1.24% 24

Other funds holding BHVN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Iron Triangle Partners's BHVN Position: Q4 2025 in Review

Iron Triangle Partners opened a new position in Biohaven (BHVN) in Q4 2025: 958,336 shares worth $10.8M. The stake represents 1.24% of the portfolio and ranks #24 among its holdings.

272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Iron Triangle Partners held 958,336 shares of Biohaven worth $10.8M as of Q4 2025.
  • Biohaven was a new Iron Triangle Partners position in Q4 2025.
  • Biohaven made up 1.24% of Iron Triangle Partners's portfolio in Q4 2025, its #24 holding.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.